BRCA2 and breast cancer: These findings are in part reminiscent of the variable penetrance for BC and OC for known high-risk CPGs, where carriers are more likely to harbour pathogenic variants in BRCA1 or BRCA2 (or PALB2) based on family history of BC and OC [40].